ReviewJournal of medical ultrasonics (2001)2023
Magnetic resonance imaging diagnosis of non-mass enhancement of the breast.
Review in Journal of medical ultrasonics (2001), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 19 citations in OpenAlex.
- Second-Look Ultrasonography for Evaluating BIRADS 3 and 4 Non Mass-Enhancement: A Cross-Sectional Study.Health science reports · 2026Article
- Magnetic resonance imaging findings of non-mass enhancements in the breast and their association with malignancy.Medicine · 2026Article
- Segmental Non-Mass Enhancement Features in Breast Magnetic Resonance Imaging: A Multicenter Retrospective Study of Histopathologic Correlations.Diagnostics (Basel, Switzerland) · 2025Article
- Histogram analysis of relaxometry from synthetic MRI for differentiation of breast BI-RADS 4 non-mass enhancement lesions.BMC medical imaging · 2025Article
- The value of intratumoral and peritumoral ultrasound radiomics model constructed using multiple machine learning algorithms for non-mass breast cancer.Scientific reports · 2025Article
- Magnetic resonance imaging features and diagnostic value analysis of non-mass enhancement lesions of the breast.Quantitative imaging in medicine and surgery · 2025Article
- Multi-sequence MRI-based nomogram for prediction of human epidermal growth factor receptor 2 expression in breast cancer.Heliyon · 2025Article
- Characteristics of Non-mass Enhancement in Contrast-enhanced Breast MRI and Associations with Malignancy.Journal of Cancer · 2025Article
- Comparison of state-of-the-art biopsy systems for ultrasound-guided breast biopsy using a chicken breast phantom.Journal of medical ultrasonics (2001) · 2024Article
- Investigation of imaging features in contrast-enhanced magnetic resonance imaging of benign and malignant breast lesions.Japanese journal of radiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast Imaging Reporting and Data System magnetic resonance imaging (BI-RADS-MRI) classifies lesions as mass, non-mass enhancement (NME), or focus. BI-RADS ultrasound does not currently have the concept of non-mass. Additionally, knowing the concept of NME in MRI is significant. Thus, this study aimed to provide a narrative review of NME diagnosis in breast MRI. Lexicons are defined with distribution (focal, linear, segmental, regional, multiple regions, and diffuse) and internal enhancement patterns (homogenous, heterogeneous, clumped, and clustered ring) in the case of NME. Among these, linear, segmental, clumped, clustered ring, and heterogeneous are the terms that suggest malignancy. Hence, a hand search was conducted for reports of malignancy frequencies. The malignancy frequency in NME is widely distributed, ranging from 25 to 83.6%, and the frequency of each finding varies. Latest techniques, such as diffusion-weighted imaging and ultrafast dynamic MRI, are attempted to differentiate NME. Additionally, attempts are made in the preoperative setting to determine the concordance of lesion spread based on findings and the presence of invasion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.